JPMorgan Chase & Co. Issues Pessimistic Forecast for Afya (NASDAQ:AFYA) Stock Price

Afya (NASDAQ:AFYA) had its target price cut by stock analysts at JPMorgan Chase & Co. from $25.00 to $20.50 in a report issued on Friday,Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 30.24% from the company’s previous close.

Separately, The Goldman Sachs Group began coverage on Afya in a report on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 price target on the stock. One research analyst has rated the stock with a sell rating and four have given a hold rating to the company. According to MarketBeat.com, Afya currently has a consensus rating of “Hold” and a consensus price target of $19.60.

Afya Price Performance

Shares of Afya stock opened at $15.74 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.60 and a current ratio of 1.60. Afya has a 52-week low of $14.52 and a 52-week high of $22.48. The stock’s 50-day simple moving average is $15.92 and its 200 day simple moving average is $16.74.

Institutional Investors Weigh In On Afya

Several institutional investors and hedge funds have recently bought and sold shares of the business. Public Employees Retirement System of Ohio bought a new position in Afya in the third quarter worth about $34,000. Quarry LP purchased a new position in Afya in the third quarter worth about $75,000. Centiva Capital LP bought a new position in Afya in the 3rd quarter valued at approximately $213,000. Quantbot Technologies LP raised its stake in shares of Afya by 73.8% in the third quarter. Quantbot Technologies LP now owns 13,268 shares of the company’s stock worth $226,000 after purchasing an additional 5,636 shares during the last quarter. Finally, Lifestyle Asset Management Inc. raised its position in Afya by 5.5% in the 4th quarter. Lifestyle Asset Management Inc. now owns 17,682 shares of the company’s stock worth $281,000 after buying an additional 929 shares during the last quarter. Hedge funds and other institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.